Clinical Trial Update: Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing paliperidone ER with quetiapine in schizophrenia has been completed to evaluate their effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)
• Quetiapine (quetiapine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED